New Matter: Inside the Minds of SLAS Scientists

Iscaffpharma Highlights Technology & Innovation AveNEW Opportunity

April 11, 2020 SLAS Episode 18
New Matter: Inside the Minds of SLAS Scientists
Iscaffpharma Highlights Technology & Innovation AveNEW Opportunity
Show Notes

Iscaffpharma CEO Per Setterberg shares how they are focusing on developing better treatments of aggressive cancers by providing 3D scaffolds mimicking human tumour environment as a platform for research and development.